Skip to main content
. 2016 Sep 29;8(4):7025–7038. doi: 10.18632/oncotarget.12347

Table 4. Univariate and Multivariate logistic regression and ROC curve analysis of mucins and associated O-glycans for colorectal polyps classification.

Univariate Analysis
Marker Diagnosis OR (95% CI) p-value AUC (95% CI) Cutpoint Sensitivity Specificity
MUC1 SSA/P vs. HP 0.411 (0.156, 1.084) 0.072 0.6772 (0.5531, 0.8012) <=0.30 0.487 0.848
SSA/P vs. TA 0.188 (0.069, 0.509) 0.001 0.7639 (0.6545, 0.8733) <=0.60 0.744 0.722
MUC4 SSA/P vs. HP 0.324 (0.160, 0.657) 0.0018 0.7257 (0.6089, 0.8425) <=1.2 0.615 0.697
SSA/P vs. TA 0.745 (0.395, 1.405) 0.36 0.5630 (0.4319, 0.6942) <=1.2 0.615 0.5
MUC17 SSA/P vs. HP 14.376 (3.664, 56.41) 0.0001 0.7739 (0.6623, 0.8855) >=0.8 0.667 0.909
SSA/P vs. TA 5.990 (1.955, 18.346) 0.0017 0.7222 (0.6047, 0.8397) >=0.80 0.667 0.778
MUC2 SSA/P vs. HP 0.530 (0.210, 1.337) 0.18 0.5960 (0.4640, 0.7279) <=1.8 0.513 0.727
SSA/P vs. TA 3.288 (1.573, 6.873) 0.0016 0.6991 (0.5765, 0.8216) >=1.60 0.718 0.583
MUC5AC SSA/P vs. HP 9.112 (2.912, 28.51) 0.0001 0.7995 (0.6947, 0.9043) >=0.9 0.769 0.727
SSA/P vs. TA 21.755 (5.985, 79.078) <0.0001 0.9081 (0.8320, 0.9842) >=0.60 0.923 0.806
Tn/STn-MUC1 SSA/P vs. HP 0.870 (0.317, 2.390) 0.79 0.5085 (0.3756, 0.6415) <=0.8 0.179 0.939
SSA/P vs. TA 2.472 (1.016, 6.016) 0.046 0.6353 (0.5095, 0.7611) >=1.2 0.795 0.444
CA19-9 SSA/P vs. HP 1.279 (0.746, 2.194) 0.37 0.5287 (0.3907, 0.6668) >2.1 0.333 0.606
SSA/P vs. TA 54.383 (6.489, 455.7) 0.0002 0.9551 (0.9095, 1.0000) >=0.80 0.872 1
Multivariate Analysis
Diagnosis Comparison AUC Lower Upper Threshold Sensitivity Specificity
SSA/P vs. HP MUC17+MUC5AC 0.865 0.776 0.954 P(SP)>= 0.4928 0.846 0.818
SSA/P vs. TA MUC1+MUC17+CA19-9 0.9868 0.97 1 P(SPT)>=0.385 0.923 0.972

HP, hyperplastic polyps; SSA/P, sessile serrated adenoma/polyps; TA, tubular adenoma; OR, odds ratio; AUC, area under curve; CI, confidence interval